Nexus Surgical

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE370Q01015
  • NSEID:
  • BSEID: 538874
INR
15.14
1.88 (14.18%)
BSENSE

Dec 26

BSE+NSE Vol: 711

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 105611,
    "name": "Nexus Surgical",
    "stock_name": "Nexus Surgical",
    "full_name": "Nexus Surgical and Medicare Ltd",
    "name_url": "stocks-analysis/nexus-surgical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "15.14",
    "chg": 1.88,
    "chgp": "14.18%",
    "dir": 1,
    "prev_price": "13.26",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538874,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE370Q01015",
    "curr_date": "Dec 26",
    "curr_time": "",
    "bse_nse_vol": "711 ",
    "exc_status": "Active",
    "traded_date": "Dec 26, 2025",
    "traded_date_str": "2025 12 26",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nexus-surgical-105611-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Nexus Surgical and Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-and-medicare-ltd-is-rated-strong-sell-3771552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NexusSurgicalan_mojoScore_3771552.png",
        "date": "2025-12-26 21:51:26",
        "description": "Nexus Surgical and Medicare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 26 December 2025, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Why is Nexus Surgical and Medicare Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nexus-surgical-and-medicare-ltd-fallingrising-3768721",
        "imagepath": "",
        "date": "2025-12-25 01:57:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Sharp Decline and Intraday Volatility</strong></p>\n<p>The stock experienced a highly volatile trading session on 24 December, with an intraday price range of ₹4.18. It touched a high of ₹17.44, representing an 11.79% increase from previous levels, before plunging to its low of ₹13.26, a 15.0% drop. This wide price fluctuation reflects heightened uncertainty among investors. Notably, the weighted average price indicates that a larger volume of shares was traded closer to the day’s low, suggesting selling pressure dominated the session.</p>\n<p><strong>Trend Reversal After Consecutive Gains</strong></p>\n<p>Prior to this steep fall, Nexus Surgical had recorded four consecutive days of gains, but the sharp decline on 24 December marks a clear trend reversal. The stock’s performance today notably ..."
      },
      {
        "title": "Nexus Surgical and Medicare Stock Falls to 52-Week Low of Rs.13.26",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-stock-hits-52-week-low-amidst-continued-downtrend-3768365",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NexusSurgicalan_priceRelatedfactors_3768365.png",
        "date": "2025-12-24 15:40:07",
        "description": "Nexus Surgical and Medicare has reached a new 52-week low of Rs.13.26, marking a significant decline in its share price amid a volatile trading session. The stock's performance contrasts sharply with broader market trends, reflecting ongoing pressures within the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Nexus Surgical Sees Revision in Market Evaluation Amidst Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nexus-surgical-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3755200",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NexusSurgical_mojoScore_3755200.png",
        "date": "2025-12-10 10:10:18",
        "description": "Nexus Surgical, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment comes amid a backdrop of subdued profit growth and valuation concerns, impacting investor sentiment and stock performance."
      },
      {
        "title": "Nexus Surgical and Medicare Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nexus-surgical-and-medicare-forms-death-cross-signalling-bearish-trend-ahead-3754223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NexusSurgicalan_dealthcross_3754223.png",
        "date": "2025-12-09 18:25:25",
        "description": "Nexus Surgical and Medicare, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price trajectory."
      },
      {
        "title": "Nexus Surgical and Medicare Q2 FY26: Profitability Surge Masks Mounting Balance Sheet Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/nexus-surgical-and-medicare-q2-fy26-profitability-surge-masks-mounting-balance-sheet-concerns-3721675",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/NexusSurgicalan_quaterlyResult_3721675.png",
        "date": "2025-11-19 11:01:37",
        "description": "Nexus Surgical and Medicare Ltd., a micro-cap medical essentials trading company, reported net profit of ₹0.17 crores for Q2 FY26, marking a sequential increase of 13.33% from Q1 FY26's ₹0.15 crores, though this represented a decline of 19.05% compared to ₹0.21 crores in Q2 FY25. The company, with a modest market capitalisation of ₹9.00 crores, has demonstrated improved profitability margins despite revenue volatility, yet its stock continues to languish, trading at ₹16.51 as of November 19, 2025—down 40.35% year-to-date and hovering near its 52-week low of ₹13.80."
      },
      {
        "title": "Why is Nexus Surgical falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nexus-surgical-fallingrising-3712825",
        "imagepath": "",
        "date": "2025-11-18 21:43:19",
        "description": "As of 18-Nov, Nexus Surgical and Medicare Ltd is experiencing a decline in its stock price, currently at 16.80, which reflects a decrease of 0.35 or 2.04%. The stock has underperformed its sector by 1.26% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 6.56% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 42.52% compared to the 5-day average, suggesting reduced interest from investors. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, Nexus Surgical has shown a 3.64% increase over the past week, which is significantly higher th..."
      },
      {
        "title": "How has been the historical performance of Nexus Surgical?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nexus-surgical-3708517",
        "imagepath": "",
        "date": "2025-11-17 22:53:13",
        "description": "Answer:\nThe historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years, culminating in the fiscal year ending March 2025.\n\nBreakdown:\nNexus Surgical's net sales have increased from 1.55 Cr in March 2023 to 5.72 Cr in March 2025, indicating strong growth. Total operating income followed a similar trend, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The company's total expenditure also grew, reaching 5.06 Cr in March 2025, up from 1.34 Cr in March 2023. Despite this increase, the operating profit (PBDIT) improved from 0.21 Cr in March 2023 to 0.67 Cr in March 2025, reflecting a healthier operating profit margin of 11.54% in March 2025 compared to 13.55% in March 2023. Profit before tax also rose from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, with profit after tax increasing from 0.17 Cr to 0.50 Cr over the same period. T..."
      },
      {
        "title": "How has been the historical performance of Nexus Surgical?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-nexus-surgical-3702862",
        "imagepath": "",
        "date": "2025-11-14 23:36:09",
        "description": "Answer:\nThe historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years.\n\nBreakdown:\nNexus Surgical's net sales have increased from 1.55 Cr in March 2023 to 5.72 Cr in March 2025, indicating strong growth. The total operating income has followed a similar trajectory, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The company's total expenditure, excluding depreciation, has also increased but at a slower rate, from 1.34 Cr in March 2023 to 5.06 Cr in March 2025, leading to an operating profit (PBDIT) of 0.67 Cr in March 2025, up from 0.22 Cr in March 2023. Profit before tax has improved from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, and profit after tax has risen from 0.17 Cr to 0.50 Cr in the same period. The earnings per share (EPS) have shown a remarkable recovery, moving from -9.69 in March 2020 to 0.91 in March 2025...."
      }
    ],
    "total": 151,
    "sid": "105611",
    "stock_news_url": "https://www.marketsmojo.com/news/nexus-surgical-and-medicare-105611"
  },
  "announcements": [
    {
      "caption": "Results - Financial Results For 30Th September 2025",
      "datetime": "14-Nov-2025",
      "details": "Submission of Unaudited Quarterly Financial Results for the quarter and half year ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th November 2025",
      "datetime": "14-Nov-2025",
      "details": "Submission of Outcome of Board Meeting held on Friday 14th November 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for The Board Meeting Of The Company Is Scheduled To Be Held On Friday 14Th November 2025 At 03:30 P.M. At The Registered Office Of The Company.",
      "datetime": "10-Nov-2025",
      "details": "Nexus Surgical And Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. The Unaudited Quarterly Financial Results of the Company for the quarter and half year ended 30th September 2025; 2. Any other business with the permission of the Chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Nexus Surgical and Medicare Ltd falling/rising?

2025-12-25 01:57:48

Sharp Decline and Intraday Volatility

The stock experienced a highly volatile trading session on 24 December, with an intraday price range of ₹4.18. It touched a high of ₹17.44, representing an 11.79% increase from previous levels, before plunging to its low of ₹13.26, a 15.0% drop. This wide price fluctuation reflects heightened uncertainty among investors. Notably, the weighted average price indicates that a larger volume of shares was traded closer to the day’s low, suggesting selling pressure dominated the session.

Trend Reversal After Consecutive Gains

Prior to this steep fall, Nexus Surgical had recorded four consecutive days of gains, but the sharp decline on 24 December marks a clear trend reversal. The stock’s performance today notably ...

Read More
stock-recommendationAnnouncement

Results - Financial Results For 30Th September 2025

14-Nov-2025 | Source : BSE

Submission of Unaudited Quarterly Financial Results for the quarter and half year ended 30th September 2025

Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th November 2025

14-Nov-2025 | Source : BSE

Submission of Outcome of Board Meeting held on Friday 14th November 2025

Board Meeting Intimation for The Board Meeting Of The Company Is Scheduled To Be Held On Friday 14Th November 2025 At 03:30 P.M. At The Registered Office Of The Company.

10-Nov-2025 | Source : BSE

Nexus Surgical And Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve 1. The Unaudited Quarterly Financial Results of the Company for the quarter and half year ended 30th September 2025; 2. Any other business with the permission of the Chair.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available